Metformin therapy and prognosis of patients with heart failure and new-onset diabetes mellitus. A propensity-matched study in the community

International Journal of Cardiology

Volumn 166, Issue 2, 2013, Pages 404-412

  Romero, Sotero P ^a   Andrey, Jose L ^a   Garcia Egido, Antonio ^a   Escobar, Miguel A ^a   Perez, Virginia ^a   Corzo, Ramón ^a   Garcia Domiguez, Gloria J ^a   Gomez, Francisco ^a  

^a HOSPITAL UNIVERSITARIO DE PUERTO REAL   (Spain)

Author keywords

Diabetes mellitus; Heart failure; Hemoglobin glycosylated; Hospitalizations; Metformin; Mortality

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; NITRATE; RECOMBINANT ERYTHROPOIETIN; SITAGLIPTIN; SULFONYLUREA; VASODILATOR AGENT;

AGED; ANEMIA; ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; DEATH; DRUG EFFECT; DYSLIPIDEMIA; FEMALE; GENDER; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPERTENSION; LACTIC ACIDOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SYSTOLIC HEART FAILURE;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HEART FAILURE; HUMANS; MALE; METFORMIN; MIDDLE AGED; POPULATION SURVEILLANCE; PROGNOSIS; PROPENSITY SCORE; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS; TREATMENT OUTCOME;

EID: 84878018230     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.10.141     Document Type: Article

References (33)

1. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood glucose control with metformin on complications in overweight patients with with type 2 diabetes (UKPDS 34) Lancet 352 1998 854 865
2. S. Salpeter, F. Greyber, G. Pasternak, and E. Salpeter Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus Cochrane Database Syst Rev 1 2006 CD002967
3. A. Holstein, D. Nahrwold, S. Hinze, and E.H. Egberts Contra-indications to metformin therapy are largely disregarded Diabet Med 16 1999 692 696
4. A.M. Emslie-Smith, D.I. Boyle, J.M. Evans, F. Sullivan, and A.D. Morris Contraindications to metformin therapy in patients with type 2 diabetes - a population based study of adherence to prescribing guidelines Diabet Med 18 2001 483 488
5. A.A. Tahrani, G.I. Varughese, J.H. Scarpello, and F.W. Hanna Metformin, heart failure, and lacic acidosis: is metformin absolutetely contraindicated? BMJ 335 2007 508 512
6. J.A. Johnson, S.R. Majumdar, S.H. Simpson, and E.L. Toth Decreased mortality associated with the use of metformin compared with sulphanylurea montherapy in type 2 diabetes Diabetes Care 25 2002 2244 2248
7. F.A. Masoudi, S.E. Inzucchi, Y. Wang, E.P. Havranek, I.M. Foody, and H.M. Krumholz Thiazolidinedones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study Circulation 111 2005 583 590
8. D.T. Eurich, S.R. Majumdar, F.A. McAlister, R.T. Tsuyuki, and J.A. Johnson Improved clinical outcomes associated with metformin in patients with diabetes and heart failure Diabetes Care 28 2002 2345 2351
9. D. Aguilar, W. Chan, B. Bozkurt, K. Ramasubbu, and A. Deswal Metformin use and mortality in ambulatory patients with diabetes mellitus and heart failure Circ Heart Fail 4 2011 53 58
10. D.T. Eurich, R.T. Tsuyuki, and S.R. Majumdar Metformin treatment in diabetes and heart failure: when academic equipoise meets clinical reality Trials 10 2009 12
11. F.M. Gomez-Soto, J.L. Andrey, and A.A. Garcia-Egido Incidence and mortality of heart failure: a community-based study Int J Cardiol 151 2011 40 45
12. F.M. Gomez-Soto, J.L. Puerto, J.L. Andrey, F.J. Fernandez, J.A. Bernal, and F. Gomez for the "Grupo para la Atención Médica Integral y Contínua" of Cádiz (GAMIC). Consultation between specialists in Internal Medicine and Family Medicine improves management and prognosis of heart failure Eur J Intern Med 19 2008 548 554
13. P.A. McKee, W.P. Castelli, P.M. McNamara, and W.B. Kannel The natural history of congestive heart failure: the Framingham study N Engl J Med 285 1971 1441 1446
14. A.D. Rule, T.S. Larson, E.J. Bergstralh, J.M. Slezak, S.J. Jacobsen, and F.G. Cosio Using serum creatinine glomerular filtration rate: accuracy in good health and in chronic kidney disease Ann Intern Med 141 2004 929 937
15. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic morbidity in longitudinal studies: development and validation Chronic Dis 40 1987 373 383
16. P.M. Mottram, and T.H. Marwick Assessment of diastolic function: what the general cardiologist needs to know Heart 91 2005 681 695
17. M.M. Redfield, S.J. Jacobsen, J.C. Burnett, D.W. Mahoney, K.B. Bailey, and R.J. Rodeheffer Burden of systolic and diastolic ventricular dysfunction in the community. Appreciating the scope of the heart failure epidemic JAMA 289 2003 194 202
18. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 34 Suppl. 1 2011 S62 S69
19. L. Rydén, E. Standl, and M. Bartnik Guidelines on diabetes, prediabetes, and cardiovascular diseases: executive summary. The task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur Heart J 28 2007 88 136
20. K.M. Goode, J. John, E.S. Kilpatrick, T. Bragadeesh, A.L. Clark, and J.G.F. Cleland Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus Heart 95 2009 917 923
21. M.R. MacDonald, M.C. Petrie, and N.H. Hawkins Diabetes, left ventricular systolic dysfunction, and chronic heart failure Eur Heart J 29 2008 1224 1240
22. M. Kamalesh Heart failure in diabetes and related conditions J Card Fail 13 2007 861 873
23. J.G. Ray, Y. Gong, K. Sykora, and J.V. Tu Statin use and survival outcomes in elderly patients with heart failure Arch Intern Med 165 2005 62 67
24. A.S. Go, W.Y. Lee, J. Yang, J.C. Lo, and J.H. Gurwitz Statin therapy and risks for death and hospitalization in chronic heart failure JAMA 296 2006 2105 2111
25. D.B. Rubin On principles for modelling propensity scores in medical research Pharmacoepidemiol Drug Saf 13 2004 855 857
26. R.B. A'Agostino Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Stat Med 17 1998 2265 2281
27. P.R. Rosenbaum Sensitivity analysis for matching with multiple controls Biometrika 75 1988 577 581
28. D. Lee, P. Austin, J. Rouleau, P. Liu, D. Naimark, and J. Tu Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model JAMA 290 2003 2581 2587
29. T.M. Therneau, and P.M. Grambsch Modeling survival data: extending the Cox model 2000 Springer New York, NY
30. K.L. Call, D. Craddock, and K. Edwards Effect of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on the rate of new-onset diabetes mellitus: a review and pooled analysis Pharmacotherapy 9 2006 1297 1306
31. L. Andren General considerations in selecting antihypertensive agents in patients with type II diabetes mellitus and hypertension Am J Med 87 1989 39S 41S
32. F.A. Masoudi, S.E. Inzucchi, Y. Wang, E.P. Havranek, J.M. Foody, and H.M. Krumholz Thiazolidinedines, metformin outcomes in older patients with diabetes and heart failure: an observational study Circulation 111 2005 583 590
33. I.L. Piña, and C. O'Connor BNP-guided therapy for heart failure JAMA 301 2009 432 434